Literature DB >> 14697858

Porcine wound models for skin substitution and burn treatment.

E Middelkoop1, A J van den Bogaerdt, E N Lamme, M J Hoekstra, K Brandsma, M M W Ulrich.   

Abstract

Skin regeneration is an important field of tissue engineering. Especially in larger burns and chronic wounds, present treatments are insufficient in preventing scar formation and promoting healing. Initial screening of potentially interesting products for skin substitution is usually done by in vitro tests. Before entering the clinic, however, in vivo studies in immunocompetent animals are necessary to prove efficacy and provide information on safety aspects. We have obtained extensive experience using the domestic pig as test animal for studies on skin replacement materials, including tissue engineered skin substitutes, and burn wound treatment. Two models are described: an excisional wound model for testing of dermal and epidermal substitutes and a burn wound model for contact and scald burns, which allows testing of modern wound dressings in comparison to the present gold standards in burn treatment. The results of these experiments show that in vivo testing was able to reveal (dis)advantages of the treatments which were not detected during in vitro studies.

Entities:  

Mesh:

Year:  2004        PMID: 14697858     DOI: 10.1016/s0142-9612(03)00502-7

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  29 in total

Review 1.  Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials.

Authors:  Xuewen Du; Jie Zhou; Junfeng Shi; Bing Xu
Journal:  Chem Rev       Date:  2015-12-08       Impact factor: 60.622

2.  Pig Induced Pluripotent Stem Cell-Derived Neural Rosettes Parallel Human Differentiation Into Sensory Neural Subtypes.

Authors:  Robin L Webb; Amalia Gallegos-Cárdenas; Colette N Miller; Nicholas J Solomotis; Hong-Xiang Liu; Franklin D West; Steven L Stice
Journal:  Cell Reprogram       Date:  2017-03-07       Impact factor: 1.987

Review 3.  Topical antimicrobials for burn infections - an update.

Authors:  Mert Sevgi; Ani Toklu; Daniela Vecchio; Michael R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-12

4.  Effect of pore size and cross-linking of a novel collagen-elastin dermal substitute on wound healing.

Authors:  Bouke K H L Boekema; Marcel Vlig; Leon Olde Damink; Esther Middelkoop; Lizette Eummelen; Anne V Bühren; Magda M W Ulrich
Journal:  J Mater Sci Mater Med       Date:  2013-11-01       Impact factor: 3.896

Review 5.  Infected animal models for tissue engineering.

Authors:  Alexander M Tatara; Sarita R Shah; Carissa E Livingston; Antonios G Mikos
Journal:  Methods       Date:  2015-04-02       Impact factor: 3.608

6.  Keratinocytes in the treatment of severe burn injury: an update.

Authors:  Liesbeth Lootens; Nele Brusselaers; Hilde Beele; Stan Monstrey
Journal:  Int Wound J       Date:  2012-09-07       Impact factor: 3.315

7.  Pig dorsum model for examining impaired wound healing at the skin-implant interface of percutaneous devices.

Authors:  Brian Mueller Holt; Daniel Holod Betz; Taylor Ann Ford; James Peter Beck; Roy Drake Bloebaum; Sujee Jeyapalina
Journal:  J Mater Sci Mater Med       Date:  2013-07-06       Impact factor: 3.896

8.  Clinical potential of a silk sericin-releasing bioactive wound dressing for the treatment of split-thickness skin graft donor sites.

Authors:  Tippawan Siritientong; Apichai Angspatt; Juthamas Ratanavaraporn; Pornanong Aramwit
Journal:  Pharm Res       Date:  2013-07-31       Impact factor: 4.200

9.  Standardization of deep partial-thickness scald burns in C57BL/6 mice.

Authors:  Jorge L Medina; Andrea B Fourcaudot; Eliza A Sebastian; Ravi Shankar; Ammon W Brown; Kai P Leung
Journal:  Int J Burns Trauma       Date:  2018-04-05

10.  A new model for preclinical testing of dermal substitutes for human skin reconstruction.

Authors:  Fabienne Hartmann-Fritsch; Thomas Biedermann; Erik Braziulis; Martin Meuli; Ernst Reichmann
Journal:  Pediatr Surg Int       Date:  2013-02-01       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.